Flavanone hydrazoneCAS# 1692-46-2 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1692-46-2 | SDF | Download SDF |
PubChem ID | 5468257.0 | Appearance | Powder |
Formula | C15H14N2O | M.Wt | 238.29 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (Z)-(2-phenyl-2,3-dihydrochromen-4-ylidene)hydrazine | ||
SMILES | C1C(OC2=CC=CC=C2C1=NN)C3=CC=CC=C3 | ||
Standard InChIKey | LTYOJFOTFBGRPP-LGMDPLHJSA-N | ||
Standard InChI | InChI=1S/C15H14N2O/c16-17-13-10-15(11-6-2-1-3-7-11)18-14-9-5-4-8-12(13)14/h1-9,15H,10,16H2/b17-13- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Flavanone hydrazone Dilution Calculator
Flavanone hydrazone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.1966 mL | 20.9828 mL | 41.9657 mL | 83.9313 mL | 104.9142 mL |
5 mM | 0.8393 mL | 4.1966 mL | 8.3931 mL | 16.7863 mL | 20.9828 mL |
10 mM | 0.4197 mL | 2.0983 mL | 4.1966 mL | 8.3931 mL | 10.4914 mL |
50 mM | 0.0839 mL | 0.4197 mL | 0.8393 mL | 1.6786 mL | 2.0983 mL |
100 mM | 0.042 mL | 0.2098 mL | 0.4197 mL | 0.8393 mL | 1.0491 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Notoginsenoside D
Catalog No.:BCX1024
CAS No.:193895-50-0
- Pseudoginsenoside
Catalog No.:BCX1023
CAS No.:96158-07-5
- Diphylloside A
Catalog No.:BCX1022
CAS No.:113558-11-5
- Soyasaponin Be
Catalog No.:BCX1021
CAS No.:117210-14-7
- Pseudostellarin A
Catalog No.:BCX1020
CAS No.:156430-20-5
- Furopelargone B
Catalog No.:BCX1019
CAS No.:1143-46-0
- Docosyl ferulate
Catalog No.:BCX1018
CAS No.:101927-24-6
- Neopuerarin A
Catalog No.:BCX1017
CAS No.:1150314-34-3
- Zeatin
Catalog No.:BCX1016
CAS No.:13114-27-7
- 6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone
Catalog No.:BCX1015
CAS No.:1622982-59-5
- Cycloastragenol-6-O-β-D-glucoside
Catalog No.:BCX1014
CAS No.:86764-12-7
- 6'-Hydroxy-3,4,2',3',4'-pentamethoxychalcone
Catalog No.:BCX1013
CAS No.:114021-62-4
- Gallic acid 4-O-β-D-glucopyranoside
Catalog No.:BCX1026
CAS No.:84274-52-2
- 18α,20β-Glycyrrhizic acid
Catalog No.:BCX1027
CAS No.:83896-44-0
- 6-Hydroxymusizin 8-glucoside
Catalog No.:BCX1028
CAS No.:23566-96-3
- Ciwujianoside D2
Catalog No.:BCX1029
CAS No.:114892-57-8
- Ciwujianoside D1
Catalog No.:BCX1030
CAS No.:114912-35-5
- Ciwujianoside C4
Catalog No.:BCX1031
CAS No.:114906-75-1
- Ciwujianoside C1
Catalog No.:BCX1032
CAS No.:114906-73-9
- Agrimoniin
Catalog No.:BCX1033
CAS No.:82203-01-8
- Acetylalkannin
Catalog No.:BCX1034
CAS No.:34232-27-4
- Isoferulic Acid
Catalog No.:BCX1035
CAS No.:537-73-5
- α-Norbixin
Catalog No.:BCX1036
CAS No.:626-76-6
- 6-Iodo 5,7,3',4',5'-Pentamethoxyflavone
Catalog No.:BCX1037
CAS No.:1192850-63-7
Crystal structures of three newly synthesized flavanone hydrazones.[Pubmed:36909992]
Acta Crystallogr E Crystallogr Commun. 2023 Feb 28;79(Pt 3):236-240.
The crystal structures of racemic mixtures of three new flavanone-hydrazones in the centrosymmetric space group (P ), are reported. The structures of (+/-,E)-N'-[5,7-dihy-droxy-2-(4-hy-droxy-phen-yl)chroman-4-yl-idene]-2-(naphthalen-1-yl)acetohydrazide ethyl acetate monosolvate, C(27)H(22)N(2)O(5).C(4)H(8)O(2), and of (+/-,E)-N'-[5,7-dihy-droxy-2-(4-hy-droxy-phen-yl)chroman-4-yl-idene]-4-hy-droxy-benzo-hydra-zide ethanol monosolvate, C(22)H(18)N(2)O(6).C(2)H(5)OH, both exhibit an intra-molecular O-Hcdots, three dots, centeredN and multiple inter-molecular O-Hcdots, three dots, centeredO and C-Hcdots, three dots, centeredO-type hydro-gen bonds. The third structure, that of (+/-,E)-N'-(6-methoxy-2-phenyl-chroman-4-yl-idene)-2-(naphthalen-1-yl-oxy)acetohydrazide, C(28)H(24)N(2)O(4), has only one inter-molecular N-Hcdots, three dots, centeredO-type hydrogen bond. In each of the three cases, the crystal packings are stabilized by pi-pi stacking inter-actions between various aromatic components of symmetry-related mol-ecules. The chiral carbon atom of the substituted chromane ring system in each case is puckered away from rest of the ring system.